2017

London, UK, 10 June 2017 BTG plc (LSE: BTG), a global specialist healthcare company, today announced the results of a pilot study evaluating the effectiveness of a digital patient engagement...

Washington, DC, 07 June 2017 The Society of Interventional Oncology (SIO), a global organization working to nurture and support interventional oncology worldwide, and global specialist healthcare...

Bothell, Washington, 22 May 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today highlights the results of the OPTALYSE PE trial, presented at the American Thoracic Society...

#, 19 May 2017 Data from a pilot study using IO Loop™ with TheraSphere® (a Y90 transarterial radioembolisation therapy) will be presented at the World Conference on Interventional Oncology BTG...

London, UK, 16 May 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today announces its final results for the year ended 31 March 2017. Click here to download the results release...

London, UK, 20 April 2017 BTG plc (LSE: BTG), a global specialist healthcare company, today announced the treatment of the first patients in the EU with DC Bead LUMI™. Two patients were treated...

London, UK, 06 April 2017 BTG plc (LSE:BTG), the specialist healthcare company, provides the following update for the year ended 31 March 2017 ahead of the publication of its Final Results on 16...

West Conshohocken, PA, 07 March 2017 BTG plc (LSE:BTG), an international specialist healthcare company, today announced that SnakeBite911™, the company’s consumer-friendly app containing...

London, UK, 07 March 2017 DC Bead LUMI™ provides real-time visible, lasting confirmation of bead location during and post-embolisation of hypervascular tumours in the liver BTG plc (LSE: BTG), a...

London, UK, 27 February 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today announced U.S. Food and Drug Administration 510(k) clearance has been granted to the EKOS® Control...